Journal profile · Ophthalmology
Journal of Glaucoma
ISSN 1057-0829 · eISSN 1536-481X · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Monthly · Founded 1992
Journal of Glaucoma: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.15; JCR Q2 (journal website); hybrid open access; median 192 days to acceptance (100 articles, last 24 months); community-reported acceptance: fairly easy; 147 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Glaucoma is published by Lippincott Williams and Wilkins Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Glaucoma and retinal disorders, Corneal surgery and disorders and Retinal Diseases and Treatments, together about 56.7% of its articles. Its main subfields are Ophthalmology and Radiology, Nuclear Medicine and Imaging. (generated from OpenAlex topic counts and CAS ranking data)
To determine whether the intraocular pressure (IOP)-lowering response to omidenepag isopropyl (OMDI) predicts the efficacy of patterned laser trabeculoplasty (PLT) in primary open angle glaucoma (POAG) patients and to assess any interaction between OMDI and PLT when used in combination.
From the journal's Aims & Scope
Research area (LetPub): Ophthalmology
Editor-in-chief Neeru GuptaPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glaucoma and retinal disordersMedicine33.8%
- Corneal surgery and disordersMedicine11.7%
- Retinal Diseases and TreatmentsMedicine11.2%
- Retinal and Macular SurgeryMedicine10.8%
- Ophthalmology and Visual Impairment StudiesMedicine7.2%
- Intraocular Surgery and LensesMedicine5.3%
- Ocular Surface and Contact LensMedicine2.6%
- Ophthalmology and Eye DisordersMedicine2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · OPHTHALMOLOGY · rank 43/98
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.15LetPub ·
- Impact factor (publisher)
- 2.2Publisher website ·
- CiteScore 2026-06
- 3.8LetPub ·
- SJR 2026-06
- 0.97LetPub ·
- SNIP 2026-06
- 1.12LetPub ·
- h-index
- 80LetPub ·
- h-index
- 122OpenAlex ·
- i10-index
- 2,861OpenAlex ·
- 2-year mean citedness
- 2.42OpenAlex ·
- Self-citation rate
- 9.1%LetPub ·
- Share of gold OA articles
- 8.55%LetPub ·
Volume
- Articles per year
- 149LetPub ·
Articles by year OpenAlex count · 5,421 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 97 | 14 | 15 |
| 2025 | 147 | 23 | 233 |
| 2024 | 177 | 39 | 772 |
| 2023 | 188 | 50 | 1,194 |
| 2022 | 191 | 69 | 1,495 |
| 2021 | 201 | 111 | 2,089 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
192 daysMedian, submission to acceptance · P25–P75 142 days – 262 days
- Acceptance to online
- median 12 days (100 articles)
- Submission to online
- median 227 days
- Sample
- 100 articles with submission and acceptance dates (278 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1992
- ISSN
- 1057-0829
- Electronic ISSN
- 1536-481X
- Latest issue on the website
- Volume 35, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Journal of Glaucoma
What CAS zone is Journal of Glaucoma in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Glaucoma is in Zone 3 of Medicine, and in Zone 3 of the minor category Ophthalmology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Glaucoma?
The latest impact factor listed by LetPub is 2.15; CiteScore 3.8, h-index 122.
How long does peer review take at Journal of Glaucoma?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 192 days (interquartile range 142–262 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Journal of Glaucoma in?
The journal's website gives JCR Q2; by category, OPHTHALMOLOGY Q2 (43/98). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Which databases index Journal of Glaucoma?
According to LetPub and DOAJ records, Journal of Glaucoma is indexed in SCIE and Scopus.
Is Journal of Glaucoma open access, and what is the APC?
Journal of Glaucoma is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .